Clinical management of atheromatous renovascular disease.
Kalra
Philip A
PA
Department of Renal Medicine, Salford Royal Hospital and University of Manchester, Salford. Philip.kalra@srft.nhs.uk
D000959:Antihypertensive Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000150:complications* / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D003952:Diagnostic Imaging; D006333:Heart Failure / Q000150:complications; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000150:complications; D007674:Kidney Diseases / Q000150:complications; D011379:Prognosis; D012077:Renal Artery / Q000473:pathology; D012078:Renal Artery Obstruction / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy*; D014656:Vascular Surgical Procedures
D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors